Ribonucleases as potential therapeutic agents

Objective Due to high cytotoxicity effect, ribonucleases (RNases) are known as pharmacological agents with therapeutic potential. The high potential of these enzymes in the destruction of RNA strand and their other substrates and subsequently, cell destruction or cessation of cell division causes a...

Full description

Bibliographic Details
Main Authors: Masoume Vakili-Azghandi, Mohammadreza Nasiri, Shahrokh Ghovvati, Ali Javadmanesh
Format: Article
Language:fas
Published: Shahid Bahonar University of Kerman 2021-03-01
Series:مجله بیوتکنولوژی کشاورزی
Subjects:
Online Access:https://jab.uk.ac.ir/article_2867_f9b259c22bd718bfd4082515cfbb4eb3.pdf
_version_ 1797389009213718528
author Masoume Vakili-Azghandi
Mohammadreza Nasiri
Shahrokh Ghovvati
Ali Javadmanesh
author_facet Masoume Vakili-Azghandi
Mohammadreza Nasiri
Shahrokh Ghovvati
Ali Javadmanesh
author_sort Masoume Vakili-Azghandi
collection DOAJ
description Objective Due to high cytotoxicity effect, ribonucleases (RNases) are known as pharmacological agents with therapeutic potential. The high potential of these enzymes in the destruction of RNA strand and their other substrates and subsequently, cell destruction or cessation of cell division causes a very high cytotoxic effect of this enzyme in various cancer cells. Hence, this review investigates the therapeutic applications of ribonucleases, cell pathways and their mode of action as cytotoxic agents in order to pay attention to them in researches related to the health and therapy fields. Materials and methods In this study the keywords such as cancer, ribonuclease, ribonuclease inhibitor and RNA were used to search in databases including Scopus, SID, IranDoc, PubMed, Google Scholar, Web of Science and IranMedex. In order to select the documents used, all articles published in non-English and Persian languages, duplicate articles, articles that could not be accessed to the full text, as well as articles that were presented as abstracts were removed. Finally, the selected cases were thoroughly studied and summarized in order to prepare the current review. Results The study and review of research conducted showed that ribonucleases have the ability to kill tumor cells and that these enzymes have antiviral properties. Bovine pancreatic ribonuclease (RNase A), bovine seminal ribonuclease (BS-RNase), Onconase, and angiogenin are known as RNases with high antitumor activity which exert cytotoxic activity on cancer cells selectively by involving different cellular pathways and/ or enhance the cytotoxicity by mutation. Also, the study of articles related to the function of ribonucleases showed that the investigation of genetic pathways of synthesis and mechanisms of cytotoxicity in these enzymes will provide the development of new pharmaceutical products in the future. Utilization of engineering processes and chemical changes in ligand / receptor structure may increase the toxicity of ribonuclease molecules in order to select cytotoxic pathways on malignant cells. Therefore, it is necessary to discover the therapeutic potential and to study in detail the therapeutic values of ribonucleases. Conclusions Ribonucleases are potentially bioavailable drug candidates, and in regard to their toxicity, which is based on the selective hydrolysis of intracellular RNA molecules and specific cell membrane recognition processes, these enzymes can be used as anti-tumor drugs or therapeutic agents.
first_indexed 2024-03-08T22:49:35Z
format Article
id doaj.art-58560e1bd65349a3823e2b8b54696f34
institution Directory Open Access Journal
issn 2228-6705
2228-6500
language fas
last_indexed 2024-03-08T22:49:35Z
publishDate 2021-03-01
publisher Shahid Bahonar University of Kerman
record_format Article
series مجله بیوتکنولوژی کشاورزی
spelling doaj.art-58560e1bd65349a3823e2b8b54696f342023-12-16T17:40:58ZfasShahid Bahonar University of Kermanمجله بیوتکنولوژی کشاورزی2228-67052228-65002021-03-01131295610.22103/jab.2021.16862.12802867Ribonucleases as potential therapeutic agentsMasoume Vakili-Azghandi0Mohammadreza Nasiri1Shahrokh Ghovvati2Ali Javadmanesh3Animal Science Department, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iranferdosi university of mashhadAnimal Science Department, Faculty of Agriculture, University of Guilan, Rasht, IranDepartment of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranObjective Due to high cytotoxicity effect, ribonucleases (RNases) are known as pharmacological agents with therapeutic potential. The high potential of these enzymes in the destruction of RNA strand and their other substrates and subsequently, cell destruction or cessation of cell division causes a very high cytotoxic effect of this enzyme in various cancer cells. Hence, this review investigates the therapeutic applications of ribonucleases, cell pathways and their mode of action as cytotoxic agents in order to pay attention to them in researches related to the health and therapy fields. Materials and methods In this study the keywords such as cancer, ribonuclease, ribonuclease inhibitor and RNA were used to search in databases including Scopus, SID, IranDoc, PubMed, Google Scholar, Web of Science and IranMedex. In order to select the documents used, all articles published in non-English and Persian languages, duplicate articles, articles that could not be accessed to the full text, as well as articles that were presented as abstracts were removed. Finally, the selected cases were thoroughly studied and summarized in order to prepare the current review. Results The study and review of research conducted showed that ribonucleases have the ability to kill tumor cells and that these enzymes have antiviral properties. Bovine pancreatic ribonuclease (RNase A), bovine seminal ribonuclease (BS-RNase), Onconase, and angiogenin are known as RNases with high antitumor activity which exert cytotoxic activity on cancer cells selectively by involving different cellular pathways and/ or enhance the cytotoxicity by mutation. Also, the study of articles related to the function of ribonucleases showed that the investigation of genetic pathways of synthesis and mechanisms of cytotoxicity in these enzymes will provide the development of new pharmaceutical products in the future. Utilization of engineering processes and chemical changes in ligand / receptor structure may increase the toxicity of ribonuclease molecules in order to select cytotoxic pathways on malignant cells. Therefore, it is necessary to discover the therapeutic potential and to study in detail the therapeutic values of ribonucleases. Conclusions Ribonucleases are potentially bioavailable drug candidates, and in regard to their toxicity, which is based on the selective hydrolysis of intracellular RNA molecules and specific cell membrane recognition processes, these enzymes can be used as anti-tumor drugs or therapeutic agents.https://jab.uk.ac.ir/article_2867_f9b259c22bd718bfd4082515cfbb4eb3.pdfribonucleasecytotoxicitydrug candidatecellular pathways
spellingShingle Masoume Vakili-Azghandi
Mohammadreza Nasiri
Shahrokh Ghovvati
Ali Javadmanesh
Ribonucleases as potential therapeutic agents
مجله بیوتکنولوژی کشاورزی
ribonuclease
cytotoxicity
drug candidate
cellular pathways
title Ribonucleases as potential therapeutic agents
title_full Ribonucleases as potential therapeutic agents
title_fullStr Ribonucleases as potential therapeutic agents
title_full_unstemmed Ribonucleases as potential therapeutic agents
title_short Ribonucleases as potential therapeutic agents
title_sort ribonucleases as potential therapeutic agents
topic ribonuclease
cytotoxicity
drug candidate
cellular pathways
url https://jab.uk.ac.ir/article_2867_f9b259c22bd718bfd4082515cfbb4eb3.pdf
work_keys_str_mv AT masoumevakiliazghandi ribonucleasesaspotentialtherapeuticagents
AT mohammadrezanasiri ribonucleasesaspotentialtherapeuticagents
AT shahrokhghovvati ribonucleasesaspotentialtherapeuticagents
AT alijavadmanesh ribonucleasesaspotentialtherapeuticagents